Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1B |
| 2 |
Merck
MRK
|
+$986M |
| 3 |
Abbott
ABT
|
+$969M |
| 4 |
NVIDIA
NVDA
|
+$967M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$814M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.46B |
| 2 |
Morgan Stanley
MS
|
+$910M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$909M |
| 4 |
Coca-Cola
KO
|
+$745M |
| 5 |
Arista Networks
ANET
|
+$692M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.51% |
| 2 | Technology | 19.42% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.08% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
iShares Core S&P 500 ETF
IVV
$884B
| $191M | 0.04% |
428,025
-14,414
| -3% | -$6.07M |
|
402
CVS Health
CVS
$134B
| $189M | 0.04% |
2,736,948
-165,264
| -6% | -$11.8M |
|
403
GATX Corp
GATX
$6.4B
| $189M | 0.04% |
1,467,615
-159,067
| -10% | -$18.6M |
|
404
Rexford Industrial Realty
REXR
$8.4B
| $187M | 0.04% |
3,580,943
-1,653,934
| -32% | -$90.2M |
|
405
Shoals Technologies Group
SHLS
$1.57B
| $186M | 0.04% |
7,280,877
+1,337,923
| +23% | +$30.9M |
|
406
Sun Communities
SUI
$15.1B
| $186M | 0.04% |
1,423,921
-741,149
| -34% | -$99.1M |
|
|
ESGR
407
DELISTED
Enstar Group
ESGR
| $185M | 0.04% |
756,366
-285,933
| -27% | -$70.7M |
|
|
IMGN
408
DELISTED
Immunogen Inc
IMGN
| $184M | 0.03% |
9,752,899
-111,886
| -1% | -$1.32M |
|
409
Inspire Medical Systems
INSP
$1.5B
| $184M | 0.03% |
565,492
-19,983
| -3% | -$5.71M |
|
410
Veracyte
VCYT
$3.58B
| $183M | 0.03% |
7,172,420
+23,342
| +0.3% | +$566K |
|
411
Ovintiv
OVV
$17.1B
| $182M | 0.03% |
4,787,114
+685,630
| +17% | +$24.8M |
|
412
JB Hunt Transport Services
JBHT
$25.1B
| $182M | 0.03% |
1,005,090
-33,880
| -3% | -$5.89M |
|
413
Guidewire Software
GWRE
$13.1B
| $181M | 0.03% |
2,381,976
-1,007,687
| -30% | -$77.1M |
|
|
ATVI
414
DELISTED
Activision Blizzard
ATVI
| $180M | 0.03% |
2,139,064
+1,171,767
| +121% | +$94.8M |
|
415
FIVE9
FIVN
$2.22B
| $179M | 0.03% |
2,174,880
-251,830
| -10% | -$16.9M |
|
416
Popular Inc
BPOP
$11.1B
| $179M | 0.03% |
2,957,187
+705,966
| +31% | +$41.6M |
|
417
Western Alliance Bancorporation
WAL
$9.04B
| $178M | 0.03% |
4,884,989
+2,801,396
| +134% | +$97.2M |
|
418
Vanguard Morningstar Small-Cap ETF
VB
$80.7B
| $178M | 0.03% |
894,715
-28,573
| -3% | -$5.4M |
|
419
First Horizon
FHN
$12.2B
| $177M | 0.03% |
15,707,462
+14,903,041
| +1,853% | +$200M |
|
420
U-Haul Holding Co Series N
UHAL.B
$12.4B
| $176M | 0.03% |
3,478,337
-94,915
| -3% | -$4.97M |
|
421
CBRE Group
CBRE
$43B
| $175M | 0.03% |
2,170,211
-31,315
| -1% | -$2.34M |
|
422
Herc Holdings
HRI
$5.48B
| $175M | 0.03% |
1,277,303
+138,079
| +12% | +$15.3M |
|
423
Aramark
ARMK
$14.9B
| $175M | 0.03% |
5,622,495
-489,186
| -8% | -$13.3M |
|
424
Celldex Therapeutics
CLDX
$2.96B
| $174M | 0.03% |
5,131,427
+949,816
| +23% | +$32M |
|
425
Charter Communications
CHTR
$17.2B
| $173M | 0.03% |
471,921
+6,192
| +1% | +$2.11M |
|
Similar funds
Wellington Management Group's Q2 2023 Portfolio in Review
As of Q2 2023, Wellington Management Group held 2,099 positions worth $527B, up 4.5% from $505B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Wellington Management Group's Q2 2023 filing shows 119 new, 718 increased, 815 reduced and 304 closed positions. Its largest new stake was Kenvue: 10,602,707 shares worth $280M. The largest sale was Eli Lilly, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q2 2023 buy was Kenvue: 10,602,707 shares worth $280M.
- Wellington Management Group added most to Gilead Sciences in Q2 2023, an estimated $1B increase.
- Wellington Management Group's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $2.46B.
- Wellington Management Group fully exited Syneos Health, Inc. Class A Common Stock in Q2 2023, selling an estimated $267M.
- Wellington Management Group's ten largest holdings make up 20% of its $527B portfolio in Q2 2023.
- Wellington Management Group opened 119 new positions and closed 304 in Q2 2023.
- Wellington Management Group's portfolio value rose 4.5% quarter-over-quarter to $527B.
Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.